devdiscourse10h
Lupin Gains USFDA Nod for Generic HIV Drug Launch
Lupin has obtained approval from the USFDA to market a generic form of an HIV medication. The approved drug, equivalent to Symtuza tablets, positions Lupin as the exclusive first-to-file. The tablets ...
Lupin shares in focus as USFDA inspection at Somerset facility concludes with no observations
Earlier in January, the company received the Establishment Inspection Report (EIR) from USFDA for its Pithampur Unit-1 ...
Lupin shares in focus post no observation from USFDA
A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...
Pharma stocks in focus after medicine tariff changes in Union Budget 2025
Finance Minister Sitharaman announced the inclusion of six life-saving drugs in the concessional 5% duty slab to enhance ...
Daily5d
USFDA nod to Lupin Ipratropium Bromide Nasal Solution for runny nose
Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...
Nifty Pharma index down over 7% in last three days; why are pharma stocks falling?
The Nifty Pharma index fell nearly 3% in intraday trade on January 28, marking its third consecutive session of decline, with Granules India, Biocon, Sun Pharma, and Lupin being the biggest losers.